A detailed history of Intech Investment Management LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 46,205 shares of BEAM stock, worth $1.24 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
46,205
Previous 44,675 3.42%
Holding current value
$1.24 Million
Previous $872,000 9.98%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025

BUY
$14.54 - $20.24 $22,246 - $30,967
1,530 Added 3.42%
46,205 $785,000
Q1 2025

May 20, 2025

BUY
$19.53 - $34.09 $298,301 - $520,690
15,274 Added 51.95%
44,675 $872,000
Q4 2024

Feb 10, 2025

BUY
$21.55 - $30.35 $183,368 - $258,248
8,509 Added 40.73%
29,401 $729,000
Q3 2024

Nov 08, 2024

BUY
$22.57 - $33.14 $471,532 - $692,360
20,892 New
20,892 $511,000

Others Institutions Holding BEAM

About Beam Therapeutics Inc.


  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.88B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.